It may also be aberrantly upregulated in a subset of tumors, leading to the overexpression of APS-positive genes such as CXCL8. Indeed, both rpS6 phosphorylation and CXCL8 expression are consistently found, by separate studies, to be tumor-promoting and upregulated in cancers. Here, RPS6 is linked to cancer.